All 50 states have applied for CMS's GENEROUS Model, a Medicaid drug pricing program expected to save $64.3 billion over the next decade. CMS recently announced that all 50 states, plus the District ...

Out-of-pocket spending, defined as co-payments, coinsurance, and deductibles standardized to a 30-day supply, was split into quintiles running from $0 to $21 at the low end to more than $168 at the ...

Pessia’s Woodlands practice relies on proximity to a partner hospital. “We’re lucky because Memorial Hermann is literally right across the parking lot, so we can transfer the patient over there fairly ...

Regulatory clearance includes Guardant360 CDx to select patients with ESR1 mutations for imlunestrant plus abemaciclib in ER+/HER2– advanced disease after endocrine-therapy progression. Phase 3 ...

Employers can advance patient-centered oncology care through proactive benefits, quality data, navigation, and tailored support, Amanda Green, MPH, said. Lalan Wilfong, MD, discusses how model ...

Diabetes care improves when support adapts to real-life changes, removing barriers and sustaining daily habits beyond reminders, education, and one-time interventions. Imagine a woman who picks up her ...

What the Data Show," Dr. Vaduganathan walks through the cardiovascular outcomes trials that built the evidence base for SGLT2 i ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Geeta Nayyar, MD, MBA, is a leading physician-technologist, investor, and globally recognized chief medical officer. Geeta Nayyar, MD, MBA, says AI's real health care payoff is cutting administrative ...

Three machine learning models trained to predict recurrent autoimmune hepatitis after liver transplantation were all outperformed by ordinary logistic regression, which reached an ...

In the phase 4 IMMpactful trial, 57.3% of biologic-naive adults with moderate psoriasis reached PASI 90 on risankizumab at week 16 against 22.9% on deucravacitinib, a gap of more than 34 percentage ...

This year’s World Alzheimer’s Day theme is “The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters,” observed September 21, 2026, bringing attention to the disease and the importance ...